O'Connor Alternative Investments’s Amicus Therapeutics FOLD Stock Holding History

O'Connor Alternative Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,444,992	Closed	-$122M	–	166
2026 Q1	$122M	Buy	+8,444,992	New	+$121M	6.4%	5

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

O'Connor Alternative Investments's FOLD Position: Q2 2026 in Review

O'Connor Alternative Investments sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 8,444,992 shares — an estimated $122M sold.

O'Connor Alternative Investments first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $122M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

O'Connor Alternative Investments reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
O'Connor Alternative Investments sold 8,444,992 Amicus Therapeutics shares in Q2 2026, an estimated $122M.
O'Connor Alternative Investments first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
O'Connor Alternative Investments's Amicus Therapeutics position peaked at $122M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on O'Connor Alternative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.